Literature DB >> 23570576

Mast cells: a pivotal role in pulmonary fibrosis.

Arul Veerappan1, Nathan J O'Connor, Jacqueline Brazin, Alicia C Reid, Albert Jung, David McGee, Barbara Summers, Dascher Branch-Elliman, Brendon Stiles, Stefan Worgall, Robert J Kaner, Randi B Silver.   

Abstract

Pulmonary fibrosis is characterized by an inflammatory response that includes macrophages, neutrophils, lymphocytes, and mast cells. The purpose of this study was to evaluate whether mast cells play a role in initiating pulmonary fibrosis. Pulmonary fibrosis was induced with bleomycin in mast-cell-deficient WBB6F1-W/W(v) (MCD) mice and their congenic controls (WBB6F1-(+)/(+)). Mast cell deficiency protected against bleomycin-induced pulmonary fibrosis, but protection was reversed with the re-introduction of mast cells to the lungs of MCD mice. Two mast cell mediators were identified as fibrogenic: histamine and renin, via angiotensin (ANG II). Both human and rat lung fibroblasts express the histamine H1 and ANG II AT1 receptor subtypes and when activated, they promote proliferation, transforming growth factor β1 secretion, and collagen synthesis. Mast cells appear to be critical to pulmonary fibrosis. Therapeutic blockade of mast cell degranulation and/or histamine and ANG II receptors should attenuate pulmonary fibrosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23570576      PMCID: PMC3624698          DOI: 10.1089/dna.2013.2005

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  46 in total

Review 1.  Mechanisms of pulmonary fibrosis.

Authors:  Victor J Thannickal; Galen B Toews; Eric S White; Joseph P Lynch; Fernando J Martinez
Journal:  Annu Rev Med       Date:  2004       Impact factor: 13.739

2.  Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent.

Authors:  P C Wong; W A Price; A T Chiu; J V Duncia; D J Carini; R R Wexler; A L Johnson; P B Timmermans
Journal:  J Pharmacol Exp Ther       Date:  1990-10       Impact factor: 4.030

3.  Mast cells show their might.

Authors:  Mitch Leslie
Journal:  Science       Date:  2007-08-03       Impact factor: 47.728

4.  Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis.

Authors:  H Y Reynolds; J D Fulmer; J A Kazmierowski; W C Roberts; M M Frank; R G Crystal
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

Review 5.  Murine models of pulmonary fibrosis.

Authors:  Bethany B Moore; Cory M Hogaboam
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-11-09       Impact factor: 5.464

6.  Up-regulation of alveolar macrophage matrix metalloproteinases in HIV1(+) smokers with early emphysema.

Authors:  Robert J Kaner; Francisco Santiago; Ronald G Crystal
Journal:  J Leukoc Biol       Date:  2009-07-15       Impact factor: 4.962

7.  Bleomycin-induced apoptosis of alveolar epithelial cells requires angiotensin synthesis de novo.

Authors:  Xiaopeng Li; Huiying Zhang; Valerie Soledad-Conrad; Jiaju Zhuang; Bruce D Uhal
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-11-15       Impact factor: 5.464

8.  Evidence of increased histamine levels of lung lavage fluids from patients with cryptogenic fibrosing alveolitis.

Authors:  P L Haslam; O Cromwell; A Dewar; M Turner-Warwick
Journal:  Clin Exp Immunol       Date:  1981-06       Impact factor: 4.330

9.  Bronchoalveolar lavage fluid histamine levels in interstitial lung diseases.

Authors:  T B Casale; S Trapp; B Zehr; G W Hunninghake
Journal:  Am Rev Respir Dis       Date:  1988-12

10.  Endothelial-derived angiocrine signals induce and sustain regenerative lung alveolarization.

Authors:  Bi-Sen Ding; Daniel J Nolan; Peipei Guo; Alexander O Babazadeh; Zhongwei Cao; Zev Rosenwaks; Ronald G Crystal; Michael Simons; Thomas N Sato; Stefan Worgall; Koji Shido; Sina Y Rabbany; Shahin Rafii
Journal:  Cell       Date:  2011-10-28       Impact factor: 41.582

View more
  28 in total

Review 1.  Update on macrophages and innate immunity in scleroderma.

Authors:  Jennifer J Chia; Theresa T Lu
Journal:  Curr Opin Rheumatol       Date:  2015-11       Impact factor: 5.006

2.  Genetic ablation of mast cells redefines the role of mast cells in skin wound healing and bleomycin-induced fibrosis.

Authors:  Sebastian Willenborg; Beate Eckes; Jürgen Brinckmann; Thomas Krieg; Ari Waisman; Karin Hartmann; Axel Roers; Sabine A Eming
Journal:  J Invest Dermatol       Date:  2014-01-09       Impact factor: 8.551

3.  Mechanical Stretch: An Important and Understudied Feature of Acute and Chronic Lung Injury.

Authors:  Leigh M Cagino; Matthew K Hensley; Sean M Fortier; Robert P Dickson
Journal:  Am J Respir Crit Care Med       Date:  2020-04-15       Impact factor: 21.405

4.  Teriparatide Treatment Improves Bone Defect Healing Via Anabolic Effects on New Bone Formation and Non-Anabolic Effects on Inhibition of Mast Cells in a Murine Cranial Window Model.

Authors:  Longze Zhang; Tao Wang; Martin Chang; Claire Kaiser; Jason D Kim; Tianyu Wu; Xiaoyi Cao; Xinping Zhang; Edward M Schwarz
Journal:  J Bone Miner Res       Date:  2017-07-19       Impact factor: 6.741

5.  Bile duct ligation-induced biliary hyperplasia, hepatic injury, and fibrosis are reduced in mast cell-deficient KitW-sh mice.

Authors:  Laura Hargrove; Lindsey Kennedy; Jennifer Demieville; Hannah Jones; Fanyin Meng; Sharon DeMorrow; Walker Karstens; Taronish Madeka; John Greene; Heather Francis
Journal:  Hepatology       Date:  2017-04-28       Impact factor: 17.425

6.  Mast cell function in prostate inflammation, fibrosis, and smooth muscle cell dysfunction.

Authors:  Goutham Pattabiraman; Ashlee J Bell-Cohn; Stephen F Murphy; Daniel J Mazur; Anthony J Schaeffer; Praveen Thumbikat
Journal:  Am J Physiol Renal Physiol       Date:  2021-08-23

Review 7.  Connecting the Dots in Emerging Mast Cell Research: Do Factors Affecting Mast Cell Activation Provide a Missing Link between Adverse COVID-19 Outcomes and the Social Determinants of Health?

Authors:  Rachel da Silveira Gorman; Iffath Unissa Syed
Journal:  Med Sci (Basel)       Date:  2022-05-28

8.  Inhibition of the stem cell factor 248 isoform attenuates the development of pulmonary remodeling disease.

Authors:  Andrew Rasky; David M Habiel; Susan Morris; Matthew Schaller; Bethany B Moore; Sem Phan; Steven L Kunkel; Martin Phillips; Cory Hogaboam; Nicholas W Lukacs
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-11-20       Impact factor: 5.464

9.  Flow Cytometric Analysis of Myeloid Cells in Human Blood, Bronchoalveolar Lavage, and Lung Tissues.

Authors:  Yen-Rei A Yu; Danielle F Hotten; Yuryi Malakhau; Ellen Volker; Andrew J Ghio; Paul W Noble; Monica Kraft; John W Hollingsworth; Michael D Gunn; Robert M Tighe
Journal:  Am J Respir Cell Mol Biol       Date:  2016-01       Impact factor: 6.914

10.  Identification of Potential ceRNA Network and Patterns of Immune Cell Infiltration in Systemic Sclerosis-Associated Interstitial Lung Disease.

Authors:  Qiuhong Wu; Yang Liu; Yan Xie; Shixiong Wei; Yi Liu
Journal:  Front Cell Dev Biol       Date:  2021-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.